Teens With T1D, Obesity Reaped Benefits of GLP-1s, Case Studies Suggest

(MedPage Today) -- Two insulin-dependent adolescents with type 1 diabetes and obesity had metabolic improvements after starting a low-dose GLP-1 agent, a case series showed. One year after adding injectable semaglutide (Ozempic, Wegovy) to lifestyle...
Source
MedPage Today
Opens original article in a new tab



